• Home
  • NEW DAY MEDICINE
  • 1 (63) 2024
  • 17 -1 (63) 2024 — Muxamedjanov A.H. — MORPHOLOGICAL AND ULTRASTRUCTURAL FEATURES OF THE THYM IN CHRONIC TOXIC HEPATITIS DUE TO PRELIMINARY SPLENECTOMY

17 -1 (63) 2024 — Muxamedjanov A.H. — MORPHOLOGICAL AND ULTRASTRUCTURAL FEATURES OF THE THYM IN CHRONIC TOXIC HEPATITIS DUE TO PRELIMINARY SPLENECTOMY

MORPHOLOGICAL AND ULTRASTRUCTURAL FEATURES OF THE THYM IN CHRONIC TOXIC HEPATITIS DUE TO PRELIMINARY SPLENECTOMY

Muxamedjanov A.H. Alfraganus University, Uzbekistan    

Resume

The work studied the morphological features of the thymus in the dynamics of experimental chronic heliotrinic hepatitis against the background of preliminary splenectomy. It was found that chronic hepatitis was accompanied by a progressive decrease in the average area of ​​the thymus lobules, especially its cortical zone. Preliminary splenectomy in the setting of chronic hepatitis promotes an increase in thymocyte proliferation and some restoration of the cellular composition of the thymic cortical zone. Consequently, in chronic hepatitis, against the background of preliminary splenectomy, there is a slight increase in lymphocytopoiesis in the thymus, and, possibly, a decrease in the degree of intrathymic destruction of thymocytes.

Key words: toxic hepatitis, spleen, thymus, splenectomy, liver.

First page

91

Last page

94

For citation: Muxamedjanov A.H. – MORPHOLOGICAL AND ULTRASTRUCTURAL FEATURES OF THE THYM IN CHRONIC TOXIC HEPATITIS DUE TO PRELIMINARY SPLENECTOMY //New Day in Medicine 2024 1(63): 91-94 https://newdaymedicine.com/index.php/2024/01/12/l-745/

LIST OF REFERENCES:

  1. Himel A.R., Taylor E.B., Phillips C.L., Welch B.A., Spann R.A., Bandyopadhyay S., Grayson B.E. Splenectomy fails to attenuate immuno-hematologic changes after rodent vertical sleeve gastrectomy. // Exp Biol Med (Maywood). 2019;244(13):1125-1135. doi: 10.1177/1535370219857991. Epub 2019 Jun 18.PMID: 31213084 Free PMC article.
  2. Hirakawa Y., Ogata T., Sasada T., Yamashita T., Itoh K., Tanaka H., Okuda K. Immunological consequences following splenectomy in patients with liver cirrhosis. // Exp Ther Med. 2019;18(1):848-856. doi: 10.3892/etm.2019.7640. Epub 2019 Jun 3.PMID: 31281459 Free PMC article.
  3. Liebman H.A., Weitz I.C. Autoimmune Hemolytic Anemia. // Med Clin North Am. 2017;101(2):351-359. doi: 10.1016/j.mcna.2016.09.007. Epub 2016 Dec 14.PMID: 28189175 Review.
  4. Sulpizio E.D., Raghunathan V., Shatzel J.J., Zilberman-Rudenko J., Worrest T., Sheppard B.C., DeLoughery T.G. Long-term remission rates after splenectomy in adults with Evans syndrome compared to immune thrombocytopenia: A single-center retrospective study. // Eur J. Haematol. 2020;104(1):55-58. doi: 10.1111/ejh.13336. Epub 2019 Oct 27.PMID: 31594025 Free PMC article.
  5. Weledji E.P. Benefits and risks of splenectomy. // Int J Surg. 2014;12(2):113-9. doi: 10.1016/j.ijsu.2013.11.017. Epub 2013 Dec 3.PMID: 24316283 Free article. Review.
  6. Worrest T., Cunningham A., Dewey E., Deloughery T.G., Gilbert E., Sheppard B.C., Fischer L.E. Immune Thrombocytopenic Purpura Splenectomy in the Context of New Medical Therapies. // J. Surg Res. 2020;245:643-648. doi: 10.1016/j.jss.2019.06.092. Epub 2019 Sep 16.PMID: 31536907
  7. Yamada S., Morine Y., Imura S., Ikemoto T., Arakawa Y., Iwahashi S., Saito Y., Yoshikawa M., Teraoku H., Shimada M. Liver regeneration after splenectomy in patients with liver cirrhosis. // Hepatol Res. 2016;46(5):443-9. doi: 10.1111/hepr.12573. Epub 2015 Oct 2.PMID: 26428414

file

download